[HTML] nature.com

[HTML][HTML] The immuno-oncological challenge of COVID-19

L Derosa, C Melenotte, F Griscelli, B Gachot… - Nature Cancer, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …
被引用次数：122 相关文章

The immuno-oncological challenge of COVID-19

L Derosa, C Melenotte, F Griscelli, B Gachot… - NATURE …, 2020 - amu.hal.science
Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …

The immuno-oncological challenge of COVID-19

L Derosa, C Melenotte, F Griscelli, B Gachot… - NATURE …, 2020 - hal.science
Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …

The immuno-oncological challenge of COVID-19

L Derosa, C Melenotte, F Griscelli, B Gachot… - 2020 - hero.epa.gov
Abstract Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …

The immuno-oncological challenge of COVID-19

L Derosa, C Melenotte, F Griscelli, B Gachot… - Nature …, 2020 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …

The immuno-oncological challenge of COVID-19.

L Derosa, C Melenotte, F Griscelli, B Gachot… - Nature Cancer, 2020 - europepmc.org
Coronavirus disease 2019 (COVID-19) and its causative virus, SARS-CoV-2, pose
considerable challenges for the management of oncology patients. COVID-19 presents as a …